Savant Capital LLC Has $4.11 Million Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Savant Capital LLC increased its position in DocuSign, Inc. (NASDAQ:DOCU) by 1.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,722 shares of the company’s stock after purchasing an additional 466 shares during the period. Savant Capital LLC’s holdings in DocuSign were worth $4,112,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Itau Unibanco Holding S.A. purchased a new position in DocuSign during the 3rd quarter worth $28,000. Brooklyn Investment Group purchased a new stake in shares of DocuSign during the third quarter valued at approximately $33,000. Modus Advisors LLC bought a new stake in DocuSign during the fourth quarter worth $36,000. Reston Wealth Management LLC purchased a new position in DocuSign in the third quarter worth $47,000. Finally, Avior Wealth Management LLC grew its stake in DocuSign by 36.5% in the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after purchasing an additional 145 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on DOCU. JMP Securities reiterated a “market outperform” rating and set a $124.00 target price on shares of DocuSign in a research note on Tuesday, January 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Tuesday, February 4th. Citigroup increased their target price on shares of DocuSign from $87.00 to $113.00 and gave the company a “buy” rating in a research report on Friday, December 6th. Jefferies Financial Group lifted their price target on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Robert W. Baird increased their price objective on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $92.45.

DocuSign Stock Performance

NASDAQ:DOCU opened at $87.92 on Wednesday. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The business’s fifty day moving average is $92.79 and its 200 day moving average is $74.72. The firm has a market cap of $17.76 billion, a price-to-earnings ratio of 18.13, a PEG ratio of 7.56 and a beta of 0.89.

Insider Activity

In other DocuSign news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $94.60, for a total value of $50,516.40. Following the transaction, the director now directly owns 7,736 shares in the company, valued at $731,825.60. This represents a 6.46 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 7,763 shares of DocuSign stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $80.54, for a total value of $625,232.02. Following the sale, the chief executive officer now owns 100,062 shares of the company’s stock, valued at approximately $8,058,993.48. This trade represents a 7.20 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 685,773 shares of company stock worth $66,032,726 over the last ninety days. Company insiders own 1.66% of the company’s stock.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.